middle.news
Artrya Unlocks $950 Per Scan Revenue with FDA Nod for Salix Plaque Module
9:09pm on Friday 29th of August, 2025 AEST
•
Healthcare
Read Story
Artrya Unlocks $950 Per Scan Revenue with FDA Nod for Salix Plaque Module
9:09pm on Friday 29th of August, 2025 AEST
Key Points
FDA 510(k) clearance granted for Salix Coronary Plaque module
Module enables rapid, point-of-care detection of high-risk coronary plaque
Integrates with existing Salix Coronary Anatomy platform already commercialized
U.S. reimbursement set at $950 per scan from January 2026
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Artrya (ASX:AYA)
OPEN ARTICLE